BioRegenx (BioRegenx) ROCE % : -30.04% (As of Mar. 2024)

View and export this data going back to . Start your Free Trial

What is BioRegenx ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. BioRegenx's annualized ROCE % for the quarter that ended in Mar. 2024 was -30.04%.

BioRegenx ROCE % Historical Data

The historical data trend for BioRegenx's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BioRegenx ROCE % Chart

BioRegenx Annual Data

Trend

Dec99

Dec00

Dec01

Dec02

Dec03

Dec04

Dec20

Dec21

Dec22

Dec23

ROCE %

Get a 7-Day Free Trial

-107.73

-75.00

-144.44

BioRegenx Quarterly Data
	Jun04	Sep04	Dec04	Mar05	Jun05	Sep05	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
ROCE %	Get a 7-Day Free Trial															-4,460.61	-19.28	-	-	-30.04

BioRegenx ROCE % Calculation

BioRegenx's annualized ROCE % for the fiscal year that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	-0.563	/	( ( (0.059 - 0.065)	+	(0.032 - 0.254) )	/ 2 )
	=	-0.563	/	( (-0.006	+	-0.222)	/ 2 )
	=	-0.563	/	-0.114
	=	493.86 %

BioRegenx's ROCE % of for the quarter that ended in Mar. 2024 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Mar. 2024 )		(Q: Dec. 2023 )		(Q: Mar. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Mar. 2024 )		(Q: Dec. 2023 )		(Q: Mar. 2024 )
	=	-2.544	/	( ( (0.032 - 0.254)	+	(20.516 - 3.355) )	/ 2 )
	=	-2.544	/	( ( -0.222	+	17.161 )	/ 2 )
	=	-2.544	/	8.4695
	=	-30.04 %

(1) Note: The EBIT data used here is four times the quarterly (Mar. 2024) EBIT data.

BioRegenx (OTCPK:BRGX) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

BioRegenx ROCE % Related Terms

Thank you for viewing the detailed overview of BioRegenx's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

BioRegenx (BioRegenx) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » BioRegenx Inc (OTCPK:BRGX) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

N/A

Address

5051 Peachtree Corners Circle, No. 200, Peachtree Corners, GA, USA, 30092

Website

https://www.findit.com

Findit Inc owns Findit.com and the Findit App. Findit.com and the Findit App operate as a Social Media Content Management Platform, that includes its own search engine. Members can utilize Findit search to submit URLs they want Findit to index in Findit search results. Nonmembers can come to Findit and enter search queries, Findit returns matching search results from content posted in Findit along with outside web pages that have been submitted.